Schonfeld Strategic Advisors LLC United Therapeutics Corp Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 20,522 shares of UTHR stock, worth $7.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

20,522

Previous 85,623 76.03%

Holding current value

$7.6 Million

Previous $19.7 Million 66.76%

% of portfolio

0.04%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $14.9 Million - $20.8 Million	-65,101 Reduced 76.03%	20,522 $6.54 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $216,661 - $256,496	1,028 Added 1.22%	85,623 $19.7 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $7.63 Million - $9.13 Million	35,523 Added 72.39%	84,595 $18.6 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $2.05 Million - $2.4 Million	9,672 Added 24.55%	49,072 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $1.57 Million - $1.78 Million	7,631 Added 24.02%	39,400 $8.7 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $10.4 Million - $13.4 Million	-48,649 Reduced 60.5%	31,769 $7.11 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $11.3 Million - $15.4 Million	54,790 Added 213.79%	80,418 $22.4 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $446,243 - $535,953	-2,195 Reduced 7.89%	25,628 $5.37 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $4.53 Million - $6.25 Million	25,923 Added 1364.37%	27,823 $6.56 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $1.88 Million - $2.42 Million	-11,300 Reduced 85.61%	1,900 $341,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $2.29 Million - $2.69 Million	-12,430 Reduced 48.5%	13,200 $2.85 Million
Q3 2021 Nov 16, 2021	BUY	$179.86 - $214.88 $3.94 Million - $4.71 Million	21,930 Added 592.7%	25,630 $4.73 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.67 Million - $2.08 Million	-9,800 Reduced 72.59%	3,700 $664,000
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $2.08 Million - $2.36 Million	13,500 New	13,500 $2.26 Million
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $216,882 - $262,973	-2,171 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $399,338 - $541,780	-4,306 Reduced 66.48%	2,171 $263,000
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $37,313 - $54,214	470 Added 7.82%	6,477 $614,000
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $5.25 Million - $6.4 Million	-67,096 Reduced 91.78%	6,007 $529,000
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $4.53 Million - $5.2 Million	60,503 Added 480.18%	73,103 $5.83 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $958,356 - $1.52 Million	12,600 New	12,600 $984,000
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $2.04 Million - $2.32 Million	-17,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $1.81 Million - $2.12 Million	17,900 New	17,900 $2.03 Million

Others Institutions Holding UTHR

# of Institutions

629

Shares Held

44.9M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC United Therapeutics Corp Transaction History